Navigation Links
AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
Date:5/16/2013

sults for a Phase 2 trial for ARX-04, a sufentanil formulation for the treatment of moderate-to-severe acute pain, funded through a grant from USAMRMC.  The company has two additional pain treatment product candidates, ARX-02 and ARX-03, which have completed Phase 2 clinical development.  For additional information about AcelRx's clinical programs, please visit www.acelrx.com.

Forward Looking Statements

This press release contains forward-looking statements, including, but not limited to, statements related to the release and anticipated timing of additional NanoTab System clinical trial data, anticipated timing of completion of AcelRx Pharmaceuticals' current clinical trials, submission of the NDA, and the therapeutic potential of AcelRx Pharmaceuticals' product candidates.  These forward-looking statements are based on AcelRx Pharmaceuticals' current expectations and inherently involve significant risks and uncertainties. AcelRx Pharmaceuticals' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to: the success, cost and timing of AcelRx Pharmaceuticals' product development activities and clinical trials; its ability to obtain and maintain regulatory approvals of its product candidates; the market potential for its product candidates; and other risks detailed in the "Risk Factors" and elsewhere in AcelRx Pharmaceuticals' U.S. Securities and Exchange Commission filings, including its Quarterly Report on Form 10-Q filed with the SEC on May 8, 2013.  AcelRx Pharmaceuticals undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.

(Logo:  h
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AcelRx Pharmaceuticals Reports First Quarter 2013 Financial Results
2. AcelRx Pharmaceuticals to Hold First Quarter 2013 Financial Results Conference Call and Webcast on May 8, 2013
3. AcelRx Pharmaceuticals Presents Positive Clinical Data for the Sufentanil NanoTab PCA System at ASRA Medical Meeting
4. Top-line Data Show AcelRx Pharmaceuticals ARX-04 Achieves Primary Endpoint in Dose-Finding Phase 2 Clinical Trial
5. AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2012 Financial Results
6. AcelRx Pharmaceuticals to Hold Fourth Quarter 2012 Financial Results Conference Call and Webcast on March 12, 2013
7. AcelRx Top-line Data Show Primary Endpoint Achieved in Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Post-Operative Pain in Major Open Abdominal Surgery Patients
8. AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences
9. AcelRx Pharmaceuticals Provides Clinical Trial Updates
10. AcelRx Appoints Adrian Adams to Board of Directors as Chairman
11. AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... July 29, 2014  Synthetic Biologics, Inc. (NYSE MKT: ... candidates targeting specific pathogens that cause serious infections and ... market activity in the Company,s stock, the NYSE MKT ... its usual practice. The Company stated that its policy ... About Synthetic Biologics, Inc. Synthetic Biologics, ...
(Date:7/29/2014)... July 29, 2014 Numotion,s Board of Directors has ... will be the company,s new Chief Executive Officer. ... career at GE where he worked primarily for GE Healthcare ... to over $5 billion. His most recent position was as ... "I am thrilled to join Numotion," said Mike ...
(Date:7/29/2014)... New York , July 29, 2014 ... by Transparency Market Research "Orthopedic Trauma Fixation Devices Market ... Analysis 2014 - 2020", the global orthopedic trauma fixation ... 2014 and is expected to grow at a CAGR ... estimated value of USD 9.3 billion in 2020. ...
Breaking Medicine Technology:Synthetic Biologics, Inc. States that Its Policy is Not to Comment on Unusual Market Activity 2Numotion Names Mike Swinford CEO 2Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 2Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 3Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 4
... 2011 Halozyme Therapeutics, Inc. (Nasdaq: HALO ... the extracellular matrix , today announced it plans ... May 6, 2011 before the open of the financial ... call with the investment community at 8:00 a.m. PDT ...
... 2011 Pharmacyclics, Inc. (NASDAQ: PCYC ), ... commercializing innovative small molecule drugs for the treatment of ... management will host a conference call and live audio ... to discuss the company,s third quarter fiscal 2011 financial ...
Cached Medicine Technology:Halozyme Therapeutics to Host First Quarter 2011 Financial Results Conference Call on May 6 2Pharmacyclics to Announce Third Quarter Fiscal 2011 Results and Host a Conference Call on May 4, 2011 2
(Date:7/29/2014)... Daily Gossip indicates in its Natural Cure for Yeast Infection ... who is looking for an all-natural holistic cure for this ... Sarah Summer, says that her method is 100 percent natural. ... this is the reason why she was so determined in ... Natural Cure for Yeast Infection review indicates that Sarah ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 For numerous women ... a relationship work can turn out being quite hard. Well, ... that he discovered the method that can help all these ... to make a guy show love and attention every day. ... revolutionary method was actually created by Alex Carter who published ...
(Date:7/29/2014)... July 30, 2014 Recent international ... devices have determined Nurse Call Systems to be ... this requires all Nurse Call Systems to be ... improves patient safety, reduces clinical risks, and is ... based Corporate Risk and Clinical Risk Committee actively ...
(Date:7/29/2014)... Denver, Colorado (PRWEB) July 29, 2014 Daily ... is a 5 step holistic system that will permanently eliminate ... to Thomas Coleman his natural treatment will banish symptoms such ... ringing or beeping sound heard by patients will be gone ... 30 to 60 days. The author of this program says ...
(Date:7/29/2014)... 2014 Daily Gossip indicates in its Acne ... to gain beautiful and clear skin in just 30 to ... these positive results even sooner than that. The new method ... used this step by step program, too. , Mike ... years. Mike battled this condition for a decade and none ...
Breaking Medicine News(10 mins):Health News:Natural Cure for Yeast Infection Review Reveals Sarah Summer’s Healing Method 2Health News:"Make Him Desire You" Review Reveals Unique Formula to Make Men Feel a Special Kind of Love 2Health News:NiQ Health Reveals the Extensive Use of Unregulated Medical Devices in Australian Hospitals 2Health News:NiQ Health Reveals the Extensive Use of Unregulated Medical Devices in Australian Hospitals 3Health News:NiQ Health Reveals the Extensive Use of Unregulated Medical Devices in Australian Hospitals 4Health News:Tinnitus Miracle Review Exposes the Only Holistic System for Tinnitus Cure 2Health News:Acne No More Review Reveals Most Effective Acne Cure Program 2
... Hospital and Columbia University Medical Center has led the ... HIV.// He is lead author and chair of the ... treatment of the disease in developed nations—presented on Aug. ... and published in the Aug. 16 Journal of the ...
... scientists childhood allergies are increasing around the world, even ... eczema have become serious// public health issues. ... being hospitalized or even dying. ,Although the ... inflammation of the airways, it is still unknown what ...
... maternity hospital was diagnosed with deadly whooping cough. As a ... as a precautionary measure. ,This woman was working ... in Camperdown. The Sydney South West Area Health Service had ... staff member ceased all contact with patients and families immediately,' ...
... epidemic of this season. This disease seems to have overshadowed ... the viral disease had been reported from Tamil Nadu, Karnataka, ... last 2 years. In Tamil Nadu alone, 49,567 people have ... · Aedes aegypti mosquito is 60 % higher than ...
... not to give unpasteurized apple juice or other unpasteurized products ... Even the elderly and people with weak immune systems are ... is that such products contain Salmonella and E. coli, which ... also said that a majority of juice n the country ...
... project that will test the clinical efficacy of Ayurvastra, ... herb// concoctions." The project was launched at the Government ... project was started by the Directorate of Handloom, Department ... Vijnan, Government Ayurveda College. The project aims to start ...
Cached Medicine News:Health News:Dr. Scott Hammer Authors Two New Guidelines for HIV Treatment 2Health News:World wide Increase in Childhood Allergies 2Health News:Beware of Chikungunya !! 2
Featuring a secure and tamper-evident adhesive closure, computer-generated Smart ScanBand can be simultaneously printed with bar code information and programmed with RFID information....
... System helps protect infants, patients, staff, and ... efficiencies, cost savings, and overall peace of ... constrained healthcare facilities., And with HALO, youre ... versatile solution, but also unique-skin sensing RFID ...
VerdaSee Dock Door Portal ID solutions provide high performance tracking of assets that enter or leave healthcare facilities through dock doors....
VerdaSee Portal ID is a family of solutions that provide automated tracking and tracing of assets as they enter or leave designated areas within a healthcare facility....
Medicine Products: